Biological treatments reshape asthma and COPD care by endotype
Biological treatments are redefining severe asthma and select COPD care through biomarker-guided use, with eosinophils remaining the strongest predictor.
Trials, guidelines and clinical evidence across Pulmonology.
Trials, guidelines and clinical evidence across Pulmonology.